Seeking AlphaThu, 09 Apr 2026 12:50:00 GMTNovaBridge's Givastomig Could Drive A Major Re-RatingNBP-0.49%
Seeking AlphaMon, 09 Mar 2026 19:27:59 GMTNovaBridge Biosciences (NBP) Discusses Phase 2a Clinical Data and Development Plan for VIS-101 in Wet Age-Related Macular Degeneration TranscriptNBP-0.49%
BenzingaMon, 09 Mar 2026 14:24:16 GMTMid-Cap NovaBridge Biosciences Stock Jumps Fueled By Positive Study Data In Eye DiseaseNBP-0.49%